Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (22)	1/15/1999 2:56:00 PM
From: Arthur Radley	Respond to of 360

Steve, I'm sure I heard this on the local news. I will give the station a call and see if I can get more info. Take a look at IFMX. This one appears to want to run to HIGHER ground.

To: Steve Lokness who wrote (22)	1/18/1999 12:05:00 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 360

Steve, This is why I think GLGC has a great future ahead. The major drug companies NEED their expertise. To: +TexasDude (27440 ) From: +Henry Niman Monday, Jan 18 1999 7:30AM ET Reply # of 27442 Speaking of sub-populations, today's WSJ has a review on the Pharmaceutical Sector, emphasizing patent expirations in the next four years and a slowing growth rate. The report suggests that advances in molecular biology will drive new products which will focus on genetically defined sub-populations